Cel Sci Corp
Biotechnology company · Vienna, Virginia, United States · NYSE: CVM
Cel Sci Corp is a biotechnology company headquartered in Vienna, Virginia, United States. Its shares trade on NYSE under the ticker CVM. It has received 8 US government small-business research awards (SBIR/STTR) from health agencies, $2.6 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $78,000 sold in a notice filed in 2018.
Cel Sci at a glance
What does Cel Sci do?
US government research funding
8 SBIR/STTR small-business research awards from US health agencies, $2.6 million in total (1998 to 2017). NIH funding came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $78,000 sold (2018).
Frequently asked questions about Cel Sci
Where is Cel Sci headquartered?
Cel Sci Corp is headquartered in Vienna, Virginia, United States.
What does Cel Sci do?
Cel Sci Corp is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Cel Sci a public company?
Yes. Cel Sci Corp trades on NYSE under the ticker CVM.
Similar companies
- Embody, Inc.Vienna, Virginia, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.